Immune Checkpoint Inhibitor Toxicity in 2018-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune Checkpoint Inhibitor Toxicity in 2018

Published:2018-10-23 Issue:16 Volume:320 Page:1702
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Johnson Douglas B.¹²,Chandra Sunandana³⁴,Sosman Jeffrey A.³⁴

Affiliation:

1. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee

2. Vanderbilt Ingram Cancer Center, Nashville, Tennessee

3. Department of Medicine, Northwestern University Medical Center, Chicago, Illinois

4. Robert H. Lurie Cancer Center, Chicago, Illinois

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference9 articles.

1. Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma.;Schadendorf;J Clin Oncol,2015

2. Immune-related adverse events associated with immune checkpoint blockade.;Postow;N Engl J Med,2018

3. Measuring toxic effects and time to treatment failure for nivolumab plus ipilimumab in melanoma.;Shoushtari;JAMA Oncol,2018

4. Safety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melanoma.;Weber;J Clin Oncol,2017

5. Pneumonitis in patients treated with anti-programmed death-1/programmed death ligand 1 therapy.;Naidoo;J Clin Oncol,2017

Cited by 203 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modulatory Role of Phytochemicals/Natural Products in Cancer Immunotherapy;Current Medicinal Chemistry;2024-10

2. The association between toxicity and efficacy of immune checkpoint inhibitors in older adults with NSCLC;Immunotherapy;2024-09-13

3. Rationally designed catalytic nanoplatform for enhanced chemoimmunotherapy via deploying endogenous plus exogenous copper and remodeling tumor microenvironment;Journal of Nanobiotechnology;2024-09-09

4. Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A Systematic Review;Diagnostics;2024-08-16

5. Delayed Pembrolizumab-Associated Sarcoidosis;American Journal of Therapeutics;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3